Trial Profile
A Multicenter, Open Label, Crossover Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Adult Subjects With Epilepsy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2020
Price :
$35
*
At a glance
- Drugs Diazepam (Primary)
- Indications Epilepsy; Seizures; Tonic-clonic epilepsy
- Focus Pharmacokinetics; Registrational
- Sponsors Aquestive Therapeutics
- 14 Mar 2019 According to an Aquestive Therapeutics media release, results from this study will be shared at upcoming medical meetings.
- 04 Dec 2018 Results presented at the 72nd Annual Meeting of the American Epilepsy Society
- 03 Dec 2018 Results presented in an Aquestive Therapeutics media release